HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.

AuthorsDavid M Alvarado, Juhee Son, Larissa B Thackray, Maria Florencia Gomez Castro, Sarada Prasad, Xueyang Cui, Naomi M Sonnek, Michael S Diamond, Siyuan Ding, Matthew A Ciorba
JournalInflammatory bowel diseases (Inflamm Bowel Dis) Vol. 28 Issue 2 Pg. 318-321 (02 01 2022) ISSN: 1536-4844 [Electronic] England
PMID34849936 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Mesalamine
  • Angiotensin-Converting Enzyme 2
Topics
  • Angiotensin-Converting Enzyme 2 (drug effects, metabolism)
  • Animals
  • COVID-19
  • Intestines (drug effects, metabolism)
  • Mesalamine (pharmacology)
  • Mice
  • SARS-CoV-2 (drug effects)
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: